Because RT was delivered before immunotherapy in all studies, it is likely that RT is able to increase the PL-D1 rate in irradiated tumor cells, bypassing problems related to PD-L1 expression that are intrinsic to ICI therapy [34]. Here, CD274 is linked to neoplasm.